What is rivaroxaban API?
“Rivaroxaban API” usually means the active pharmaceutical ingredient (API) used to make medicines containing rivaroxaban, a prescription anticoagulant (blood thinner) used to help prevent or treat blood clots.
What is rivaroxaban used for?
Rivaroxaban is used in clinical practice for conditions where reducing the risk of harmful clot formation is important (for example, preventing stroke in certain patients with atrial fibrillation and treating or preventing deep vein thrombosis/pulmonary embolism). The exact labeled uses depend on the specific product and country.
How is rivaroxaban API sold and regulated?
The “API” is typically manufactured by API suppliers and then formulated into finished drug products by pharmaceutical companies. In most markets, the finished product must be approved by regulators, and the API must meet quality and manufacturing requirements (such as GMP and relevant pharmacopoeial/spec specifications). Exact regulatory details depend on the destination country and the finished dosage form.
Where can I find information about rivaroxaban patents and manufacturers?
If your goal is sourcing or assessing legal status (for example, who holds patents and when they may expire), DrugPatentWatch.com tracks patent and exclusivity information. You can search there for rivaroxaban here: https://www.drugpatentwatch.com/patent/ (site search is needed for “rivaroxaban”).
If you meant “rivaroxaban API” for sourcing: what details should you confirm?
People looking for an API typically need to verify supplier qualification and technical documentation (for example, intended grade/specs, GMP status, CoA/CoC availability, and regulatory filings). The exact requirements vary by buyer (finished-dose manufacturer vs. distributor) and by country.
Can you clarify what you need?
“Rivaroxaban api” can mean different things depending on your use case. Tell me which of these you want and I’ll tailor the answer:
1) API manufacturing/sourcing requirements (GMP, documentation)
2) Patent/exclusivity status and key dates
3) Clinical uses and dosing at a high level
4) Regulatory/quality expectations for API in a specific country (US/EU/India, etc.)
Sources
- https://www.drugpatentwatch.com/patent/